C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.author이윤희-
dc.contributor.author김세미-
dc.date.accessioned2020-09-11T01:56:14Z-
dc.date.available2020-09-11T01:56:14Z-
dc.date.issued2017-09-19-
dc.identifier.other1009VUS-2-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/20564-
dc.description.abstractAs explained hereinbefore, the C12orf59 gene of the present invention suppresses cancer cell invasion and inhibits cancer cell survivability, and the over expression of C12orf59 protein or a fragment thereof inhibits cancer cell invasion, so that C12orf59 gene or a fragment thereof not only can be effectively used for the pharmaceutical composition for preventing and treating cancer but also can be used as a clinical marker for screening a cancer treatment agent candidate, for diagnosing various cancers or for predicting pathological stage. In addition, the C12orf59 gene or a fragment thereof of the present invention can be used for the method for preventing and treating cancer and for the preparation of a pharmaceutical composition for preventing and treating cancer.-
dc.titleC12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물-
dc.title.alternativePharmacological composition containing C12orf59-derived peptides for the prevention and treatment of cancer-
dc.typePatent-
dc.date.registration2017-09-19-
dc.contributor.affiliatedAuthor이윤희-
dc.contributor.affiliatedAuthor김세미-
dc.date.application2015-03-20-
dc.identifier.patentApplicationNumber14/664,048-
dc.identifier.patentRegistrationNumber9,765,118-
dc.publisher.location미국-
dc.contributor.assignee한국생명공학연구원-
dc.contributor.inventor김세미-
dc.description.patentCountryDivision국외-
Appears in Collections:
Division of Biomedical Research > Microbiome Convergence Research Center > 2. Patents
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.